https://www.ema.europa.eu/medicines/human/EPAR/Ryzodeg 2013 false United Kingdom English French insulin degludec and insulin aspart insulin degludec, insulin aspart drug combination insulin degludec, insulin aspart drug combination insulin aspart drug combinations drug approval europe treatment outcome insulin, long-acting insulin, long-acting hypoglycemic agents hypoglycemic agents injections, subcutaneous diabetes mellitus, type 1 diabetes mellitus, type 2 summary of product characteristics package leaflet drug evaluation syndication feed recombinant proteins adult aged drug interactions pregnancy breast feeding fertility randomized controlled trials as topic Glycated Hemoglobin drug combinations drug combinations insulin aspart insulin degludec insulin degludec